Adenomyosis and endometriosis are gynecologic processes with characteristic pathophysiologic, clinical, and imaging differences. Although adenomyosis refers to the presence of heterotopic endometrial glands and stroma within the myometrium, endometriosis involves the presence of endometrial glands and stroma outside of the uterus (Figure 1). Patients with either adenomyosis or endometriosis can have a similar clinical presentation. Imaging can be of great utility in differentiating between these 2 gynecologic pathologic processes, thereby guiding appropriate clinical management. Accurate diagnosis also is important because endometriosis has potentially more signifi cant complications. Finally, differentiating an ovarian endometrioma from its mimics can obviate the need for more invasive procedures, such as laparoscopy or oophorectomy.

Adenomyosis of the Uterus
Adenomyosis of the uterus represents heterotopic endometrial glands and stroma in the myometrium with adjacent smooth muscle hypertrophy. The pathogenesis of uterine adenomyosis involves endometrial migration via a basement membrane defect or through lymphatic or vascular channels. 1 Women age 40 to 50 years usually are affected. Although patients with uterine adenomyosis are usually asymptomatic, symptoms may include pelvic pain, menorrhagia, and dysmenorrhea. Risk factors for uterine adenomyosis include prior uterine trauma or surgery, multiparity, and hyperestrogenemia. Imaging is important because superfi cial uterine adenomyosis responds signifi cantly better to endometrial ablation than does deep uterine adenomyosis. On ultrasound imaging, pseudowidening of the endometrium with a poorly defi ned endomyometrial junction often is seen in diffuse uterine adenomyosis because of heterotopic endometrium extending into the inner myometrium 2 ( Figure 2 ). These heterotopic endometrial glands cause an appearance of subendometrial echogenic linear striations. 2 Also, the uterus is often globular and enlarged with heterogeneous myometrial echotexture.
On MRI, diffuse uterine adenomyosis demonstrates thickening of the junctional zone of at least 12 mm. The junctional zone corresponds to the innermost layer of myometrium and is visualized as a distinct area of low signal on T2-weighted MR images, separating the high-signal endometrium from the intermediate-signal outer myometrium 3 ( Figure 3 ). Although a junctional zone thickness greater than 12 mm is diagnostic of uterine adenomyosis (Figure 4 ), a junctional zone thickness of 8 mm or less effectively excludes adenomyosis as a diagnostic consideration. (see Figure 4) , and T1-hyperintense punctuate foci indicating hemorrhage, all of which are fi ndings that add specifi city to the diagnosis. Because of its superior sensitivity and specifi city compared with ultrasound, MRI is the imaging modality of choice for the diagnosis of uterine adenomyosis. 2 The defi nitive treatment for diffuse uterine adenomyosis is hysterectomy, particularly in women with debilitating symptoms. Endometrial ablation can be performed for more superfi cial disease, which is best evaluated on MRI. 2 Mimics of Focal Adenomyosis. A myometrial contraction could mimic focal adenomyosis, but myometrial contractions are transient and change in appearance over time. 2 Although typically diffuse, uterine adenomyosis also can occur focally and even appear mass-like as an adenomyoma. Uterine leiomyomas (fibroids) are well-defined, rounded lesions with mass effect on the endometrium, unlike focal uterine adenomyosis, which is poorly defi ned, elliptical, and without mass effect. Although both uterine fi broids and adenomyosis are hypointense on T2-weighted MR images, focal uterine adenomyosis contains punctate hyperintense foci, signifying dilated cystic endometrial glands. 2 Differentiating the two conditions is clinically relevant because of divergent management: uterine conservation with myomectomy for leiomyomas versus hysterectomy for uterine adenomyosis.
Additional MR fi ndings include poorly defi ned junctional zone margins, intrazonal T2-hyperintense punctate foci representing cystic dilatation of heterotopic glands 3 endometriomas. 4 Less commonly, endometriomas may demonstrate echogenic wall nodularity and have thin or thick septations. 6 Ultrasound is highly sensitive and specifi c in the evaluation of endometriomas. However, ultrasound is extremely poor in evaluating the other forms of endometriosis (i.e., endometrial implants and deep pelvic endometriosis with adhesions), 6 which are thought to be the principal causes of pelvic pain and infertility in affected patients.
The most common and specifi c MR appearance of endometriomas is the presence of lesions that are homogeneously T1-hyperintense (referred to as "light bulb bright") and T2-hypointense (referred to as "T2 shading") 5 ( Figures 6A and  6B ). T2 shading occurs because of the high concentration of iron and protein and increased viscosity and protein crosslinking within the lesion. 6 Less commonly, endometriomas can appear T2-hyperintense because of differences in concentration of blood products. A defi nitive diagnosis of an endometrioma is made if there is a T1-hyperintense lesion with T2 shading or if multiple T1-hyperintense cysts are visualized, regardless of their signal intensity on T2-weighted images. 6 MRI is the most specifi c modality for diagnosis of endometriosis, with a sensitivity of 90% and a specifi city of 98%. 6 A T1-weighted, fat-suppressed sequence further improves sensitivity, as fat suppression narrows the dynamic signal range and increases lesion conspicuity, allowing detection of endometriomas and endometrial implants as small as 5 mm (Figure 7 ). 6 
Endometriosis
Endometriosis represents functional ectopic endometrial glands and stroma outside of the uterine cavity. Endometriosis is in some ways similar to uterine adenomyosis, which was formerly referred to as endometriosis interna. 1 The most accepted theory of the pathogenesis of endometriosis is that it results from metastatic implantation of endometrial tissue into the peritoneal cavity from retrograde menstruation. 4 Endometriosis is seen predominantly in women of childbearing age, with an overall prevalence of 10%. In addition, 5% of cases are seen in postmenopausal women. 5 The most common presenting symptoms are pelvic pain and infertility. Risk factors include age and prolonged exposure to menstruation, such as early menarche, nulliparity, short menstrual cycles, and prolonged menstrual fl ow. 4 Endometriosis can present in three forms: ovarian endometriomas, endometrial implants, and deep pelvic endometriosis with adhesions.
Endometriomas are chronic cysts that occur within the ovary from repeated cyclic hemorrhage. These ovarian endometrial cysts are referred to as "chocolate cysts" because they contain thick, dark, degenerated blood products. 4 On ultrasound, endometriomas contain homogeneously diffuse low-level echoes ( Figure 5 ), a fi nding observed in 95% of There are numerous potential sites of implantation in endometriosis. The gastrointestinal (GI) tract is the most common site, occurring in 12% to 37% of cases, most commonly the rectosigmoid colon. Serosal, and less commonly, transmural implantation may occur, with patients experiencing bloating, cramping, and pain during defecation. 7 The urinary tract is the next most common site of involvement in up to 20% of cases, typically involving the urinary bladder, followed by the ureters. Patients may present with urinary urgency, dysuria, and gross hematuria. 7 Up to 30% of women with endometriosis have fallopian tube involvement at laparoscopy, with hematosalpinx likely occurring secondary to adhesions. Hematosalpinx appears as a T1-hyperintense tubular adnexal structure and may be an isolated fi nding in a patient with endometriosis. The thorax is a rare site of involvement but is the most frequent form of extra-abdominal endometriosis. The thoracic endometriosis syndrome manifests as catamenial pneumothorax, hemothorax, and lung nodules ( Figure  8 ). Women with thoracic endometriosis can present with pleuritic chest pain, pleural effusions, or cyclic hemoptysis. 7 The treatment for endometriosis is medical when symptoms include pelvic pain or dyspareunia, usually with antiinfl ammatory agents or hormonal therapy. In the case of infertility, treatment is surgical, which involves the removal of endometriomas or lysis of adhesions in a patient with deep pelvic endometriosis. 7 Mimics of Endometriosis. Hemorrhagic cysts, mature cystic teratomas, and ovarian mucinous epithelial neoplasms Figure 8 . Axial CT scan demonstrates thoracic endometrial seeding with pleural thickening (calipers), round atelectasis (circle) secondary to chronic pleural irritation, and a pleural effusion found to be a hemothorax.
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are part of the differential diagnosis, but there are useful imaging characteristics that can help differentiate these mimics from endometriomas. Hemorrhagic cysts are usually solitary, unilocular, evolve into more complex-appearing cysts over time, and resolve within 6 weeks, unlike endometriomas that persist. 7 On ultrasound, hemorrhagic cysts typically demonstrate a reticular pattern of echogenic Rokitansky nodule pathognomic for a dermoid cyst typically is visible on CT ( Figure 10B ) and especially MRI. On MRI, T1 fat-suppressed imaging differentiates dermoid cysts from endometriomas with high specifi city. 7 Borderline mucinous epithelial ovarian tumors may demonstrate low-level echoes on ultrasound because of loculated mucin and, therefore, may resemble endometriomas ( Figure  11 ). However, these tumors are typically much larger than endometriomas. On MRI, these lesions may be multilocular, have enhancing solid components, or have a "stained glass" appearance because of variations in mucin concentration within loculi. 6 Complications of Endometriosis. Malignant transformation is rare in endometriosis, occurring less than 1% of the time. The most common malignancies arising from endometriosis are endometrioid carcinoma (Figure 12 ) followed by clear cell carcinoma 6 (Figure 13 ). The most reliable imaging fi nding in evaluating for malignant transformation of an endometrioma is the presence of an MRI contrast-enhancing or Doppler-positive mural nodule (see Figure 13) . 4 On MRI, enhancing mural nodules are sensitive (97%) but not specifi c (56%) for malignant transformation. 5 Other, less reliable imaging features suggesting malignant transformation include loss of T2 shading and interval increase in size. 5 Scar endometriosis represents iatrogenic spread of endometrial tissue related to surgery, a complication seen in 1% of all patients who have had a cesarean delivery. Patients can present with a palpable mass or cyclical pain weeks to years after surgery. 6 On ultrasound, a solid hypoechoic mass is seen with internal vascularity on Doppler imaging. On CT, a soft tissue density is encountered in the subcutaneous tissues of the abdominal wall in the expected region of a Pfannenstiel incision 6 (Figure 14) . Tissue sampling typically is required to confi rm the diagnosis.
Conclusion
Uterine adenomyosis and endometriosis are gynecologic processes with often overlapping clinical symptoms. This CME activity emphasizes the key imaging differences between these two entities and differentiates them from their mimics, thereby guiding appropriate therapy. Transvaginal ultrasound of an adnexal lesion demonstrates low-level echoes, resembling an endometrioma. However, this lesion is larger than a typical endometrioma and is a pathology-proven borderline mucinous epithelial ovarian tumor, which could be characterized more defi nitively on MRI.
fi brin strands ( Figure 9A ), as opposed to the homogeneous low-level echoes of endometriomas. 7 On MRI, hemorrhagic cysts are usually both T1-and T2-hyperintense ( Figures 9B and 9C) . Moreover, hemorrhagic cysts are clotforming rather than viscous and contain little iron (i.e., no "T2 shading"). 7 Mature cystic teratomas (dermoid cysts), particularly those with high sebum content, may mimic endometriosis on ultrasound and appear as cystic masses with low-level internal echoes similar to an endometrioma ( Figure 10A ). If not detected on ultrasound, the fat and calcium-containing Figure 12 . Endometrioid carcinoma. Axial CT scan of a large bilobed right adnexal mass. This was a pathology-proven endometrioid carcinoma, the most common malignancy to arise from endometriosis. In addition, there is synchronous endometrial hyperplasia, a fi nding that occurs in 30% of patients with endometrioid carcinoma. Figure 13 . Clear cell carcinoma of the ovary. Ultrasound of a cystic adnexal lesion with papillary projections (arrow) demonstrates intranodular Doppler fl ow, raising suspicion for malignant transformation. This lesion was a pathology-proven clear cell carcinoma, the second most common malignancy to arise from endometriosis. Figure 14 . Scar endometriosis. Axial CT scan of a biopsyproven subcutaneous endometrial implant (dashed arrow) along a transverse incision site secondary to iatrogenic spread from a cesarean delivery.
